Jeffrey MING
Inventor
Stats
- 1 US patents issued
- 9 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 9 US Applications Filed
- 78 Total Citation Count
- Oct 26, 2023 Most Recent Filing
- Aug 20, 2013 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| SANOFI BIOTECHNOLOGY | 3
1 | 2013
2017 |
| REGENERON PHARMACEUTICALS, INC. | 3
2 | 2013
2017 |
Inventor Addresses
| Address | Duration |
|---|---|
| Bridgewater, NJ, US | Feb 27, 14 - Jun 20, 24 |
| Bryn Mawr, PA, US | Oct 04, 18 - Jun 27, 24 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 9 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 3 |
| C07K: | PEPTIDES | 9 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0207,397 | 2024 | TREATMENT OF LUPUS USING HUMANIZED ANTI-CXCR5 ANTIBODIES | 0 |
| 2024/0199,751 | 2024 | METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST | 0 |
| 11845800 | 2023 | Methods for treating or preventing asthma by administering an IL-4R antagonist | 0 |
| 2023/0058,395 | 2023 | METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST | 1 |
| 2021/0077,619 | 2021 | TREATMENT OF LUPUS USING HUMANIZED ANTI-CXCR5 ANTIBODIES | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.